BTAI
Price
$1.93
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
11.69M
SYBX
Price
$1.18
Change
-$0.02 (-1.67%)
Updated
Jul 3 closing price
Capitalization
13.8M
Interact to see
Advertisement

BTAI vs SYBX

Header iconBTAI vs SYBX Comparison
Open Charts BTAI vs SYBXBanner chart's image
BioXcel Therapeutics
Price$1.93
Change-$0.00 (-0.00%)
Volume$78.65K
Capitalization11.69M
Synlogic
Price$1.18
Change-$0.02 (-1.67%)
Volume$18.83K
Capitalization13.8M
BTAI vs SYBX Comparison Chart in %
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. SYBX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Buy and SYBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BTAI: $1.93 vs. SYBX: $1.18)
Brand notoriety: BTAI and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 25% vs. SYBX: 189%
Market capitalization -- BTAI: $11.69M vs. SYBX: $13.8M
BTAI [@Biotechnology] is valued at $11.69M. SYBX’s [@Biotechnology] market capitalization is $13.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, SYBX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 6 TA indicator(s) are bullish while SYBX’s TA Score has 5 bullish TA indicator(s).

  • BTAI’s TA Score: 6 bullish, 4 bearish.
  • SYBX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than SYBX.

Price Growth

BTAI (@Biotechnology) experienced а -4.93% price change this week, while SYBX (@Biotechnology) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYBX($13.8M) has a higher market cap than BTAI($11.7M). SYBX YTD gains are higher at: -15.714 vs. BTAI (-67.739). SYBX has higher annual earnings (EBITDA): -13.66M vs. BTAI (-24.24M). BTAI has more cash in the bank: 31M vs. SYBX (17.3M). SYBX has less debt than BTAI: SYBX (0) vs BTAI (106M). BTAI has higher revenues than SYBX: BTAI (1.85M) vs SYBX (0).
BTAISYBXBTAI / SYBX
Capitalization11.7M13.8M85%
EBITDA-24.24M-13.66M178%
Gain YTD-67.739-15.714431%
P/E RatioN/A5.36-
Revenue1.85M0-
Total Cash31M17.3M179%
Total Debt106M0-
FUNDAMENTALS RATINGS
BTAI vs SYBX: Fundamental Ratings
BTAI
SYBX
OUTLOOK RATING
1..100
2450
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
6061
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BTAI's Valuation (80) in the Biotechnology industry is in the same range as SYBX (86). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

BTAI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for BTAI (100). This means that SYBX’s stock grew somewhat faster than BTAI’s over the last 12 months.

BTAI's Price Growth Rating (60) in the Biotechnology industry is in the same range as SYBX (61). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's P/E Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for BTAI (100). This means that SYBX’s stock grew somewhat faster than BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAISYBX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 27 days ago
80%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUPV10.750.12
+1.13%
Grupo Supervielle SA
ADNT22.380.20
+0.90%
Adient plc
EQ0.32N/A
+0.78%
Equillium
WLK81.11-0.74
-0.90%
Westlake Corp
SGMO0.53-0.01
-1.51%
Sangamo Therapeutics

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
N/A
TENX - BTAI
37%
Loosely correlated
+1.22%
SYBX - BTAI
37%
Loosely correlated
-1.67%
CRSP - BTAI
33%
Loosely correlated
+0.97%
SBHMY - BTAI
32%
Poorly correlated
N/A
RXRX - BTAI
31%
Poorly correlated
+1.15%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with SBHMY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then SBHMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
-1.67%
SBHMY - SYBX
39%
Loosely correlated
N/A
BTAI - SYBX
37%
Loosely correlated
N/A
SPHRF - SYBX
29%
Poorly correlated
N/A
ATXS - SYBX
29%
Poorly correlated
+1.40%
ALT - SYBX
28%
Poorly correlated
-2.86%
More